Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.23
2.01
NAV
₹371.26
₹574.88
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1307.98 Cr
₹4997.72 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
9.78%
12.39%
3 Year
23.96%
22.49%
5 Year
13.89%
15.98%
Equity
95.05%
97.16%
Cash
4.95%
2.78%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.54% |
Ajanta Pharma Ltd. | 5.08% |
Divi's Laboratories Ltd. | 4.74% |
Gland Pharma Ltd. | 4.11% |
Caplin Point Laboratories Ltd. | 4.02% |
Lupin Ltd. | 3.77% |
Apollo Hospitals Enterprise Ltd. | 3.52% |
Alkem Laboratories Ltd. | 3.14% |
Dr. Reddy's Laboratories Ltd. | 3.01% |
Max Healthcare Institute Ltd. | 2.98% |
Sun Pharmaceutical Industries Ltd. | 11.18% |
Acutaas Chemicals Ltd. | 6.35% |
Divi's Laboratories Ltd. | 5.92% |
Apollo Hospitals Enterprise Ltd. | 5.21% |
Max Healthcare Institute Ltd. | 5.08% |
Aurobindo Pharma Ltd. | 4.17% |
Aster DM Healthcare Ltd. | 3.77% |
Laurus Labs Ltd. | 3.64% |
Cipla Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
